Kornitzer Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Hold |
10,270
| – | – | 0.01% | 443 |
|
|
2025
Q1 | $726K | Buy |
10,270
+2,300
| +29% | +$163K | 0.02% | 399 |
|
|
2024
Q4 | $524K | Hold |
7,970
| – | – | 0.01% | 427 |
|
|
2024
Q3 | $560K | Buy |
7,970
+1,850
| +30% | +$130K | 0.01% | 428 |
|
|
2024
Q2 | $504K | Sell |
6,120
-42,398
| -87% | -$3.49M | 0.01% | 436 |
|
|
2024
Q1 | $4.24M | Hold |
48,518
| – | – | 0.08% | 266 |
|
|
2023
Q4 | $4.68M | Buy |
+48,518
| New | +$4.68M | 0.09% | 257 |
|
|
2020
Q3 | – | Sell |
-159,651
| Closed | -$19.7M | – | 490 |
|
|
2020
Q2 | $19.7M | Buy |
+159,651
| New | +$19.7M | 0.4% | 84 |
|
|
2015
Q1 | – | Sell |
-154,600
| Closed | -$14M | – | 451 |
|
|
2014
Q4 | $14M | Sell |
154,600
-27,100
| -15% | -$2.45M | 0.16% | 150 |
|
|
2014
Q3 | $13.1M | Sell |
181,700
-200
| -0.1% | -$14.4K | 0.15% | 157 |
|
|
2014
Q2 | $11.3M | Buy |
181,900
+169,300
| +1,344% | +$10.5M | 0.12% | 182 |
|
|
2014
Q1 | $859K | Buy |
+12,600
| New | +$859K | 0.01% | 364 |
|